Compound Evidence File
#EC-2026-0628
Epithalon
Filed under Peptides. The bureau holds 179 laboratory returns for this compound from 73 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
73 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 10.0 | 10.0 | 2 Apr 2026 | 26 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Nov 2025 | 6 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Jan 2026 | 28 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Apr 2026 | 28 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 27 Jan 2026 | 10 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Dec 2025 | 6 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Dec 2025 | 14 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Jan 2026 | 17 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Dec 2025 | 4 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Mar 2026 | 23 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 25 Feb 2026 | 14 Apr 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 10.0 | 10.0 | 10.0 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Nov 2025 | 9 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Mar 2026 | 11 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 16 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Jun 2026 | 16 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 1 Jul 2026 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Mar 2026 | 2 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Jan 2026 | 15 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Jun 2026 | 15 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Feb 2026 | 5 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Jul 2026 | 16 Aug 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 9.5 | 9.5 | 9.5 | 13 Feb 2025 | 13 Feb 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 9.2 | 9.2 | 9.2 | 3 Jun 2025 | 3 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 9.0 | 8.6 | 9.4 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.8 | 7.2 | 10.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.4 | 7.1 | 10.0 | 21 May 2026 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.2 | 8.2 | 8.2 | 27 Feb 2025 | 27 Feb 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.1 | 7.1 | 10.0 | 23 May 2026 | 23 May 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 8.0 | 8.0 | 8.0 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 7.9 | 6.0 | 8.9 | 25 May 2026 | 25 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 7 | 7.9 | 3.1 | 9.9 | 21 May 2025 | 24 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 3 | 7.8 | 6.6 | 10.0 | 7 May 2025 | 26 Jan 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 2 | 7.8 | 7.1 | 8.5 | 24 Apr 2025 | 26 Jan 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 6 | 7.7 | 3.5 | 10.0 | 13 Jun 2025 | 21 May 2026 |
| PeptiSlimCASE #VI-2026-0557 | X | 1 | 7.7 | 7.7 | 7.7 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 | 28 Mar 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 7.6 | 7.6 | 7.6 | 6 May 2025 | 6 May 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 7.5 | 6.4 | 8.5 | 3 Jun 2025 | 24 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 | 28 Mar 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.4 | 7.4 | 7.4 | 13 Feb 2025 | 13 Feb 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 | 20 Jun 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 3 | 7.2 | 5.4 | 8.6 | 20 Jun 2025 | 24 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 1 | 7.0 | 7.0 | 7.0 | 13 Jun 2025 | 13 Jun 2025 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 2 | 6.8 | 6.6 | 7.0 | 8 Jul 2025 | 24 May 2026 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 6.8 | 6.8 | 6.8 | 8 Jul 2025 | 8 Jul 2025 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 | 17 Dec 2024 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 6.7 | 6.7 | 6.7 | 9 Jun 2025 | 9 Jun 2025 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 3 | 6.5 | 6.1 | 6.9 | 8 Jul 2025 | 21 May 2026 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 8 | 6.4 | 4.0 | 10.0 | 25 Apr 2025 | 21 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.3 | 6.3 | 6.3 | 8 Jul 2025 | 8 Jul 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 6.3 | 6.3 | 6.3 | 9 Jun 2025 | 9 Jun 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 6.1 | 4.3 | 7.9 | 25 Apr 2025 | 24 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.1 | 6.1 | 6.1 | 7 May 2025 | 7 May 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 | 2 Jul 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 5.9 | 5.9 | 5.9 | 13 Feb 2025 | 13 Feb 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 | 11 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 5.4 | 5.4 | 5.4 | 20 Jun 2025 | 20 Jun 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 5.3 | 5.3 | 5.3 | 14 Jan 2025 | 14 Jan 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 5.0 | 5.0 | 5.0 | 21 May 2025 | 21 May 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Apr 2025 | 2 Apr 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 2 | 4.7 | 4.3 | 5.0 | 16 Mar 2025 | 24 May 2026 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 4.0 | 4.0 | 4.0 | 3 Jul 2025 | 3 Jul 2025 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 3.6 | 3.6 | 3.6 | 8 Jul 2025 | 8 Jul 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 3 | 3.5 | 2.9 | 4.0 | 24 Apr 2025 | 24 May 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 3.1 | 3.1 | 3.1 | 13 Jun 2025 | 13 Jun 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.6 | 0.6 | 0.6 | 8 Jul 2025 | 8 Jul 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jun 2025 | 3 Jun 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Apr 2025 | 2 Apr 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for Epithalon alone.